Xarelto-Drug Insights,2014

Transcription

1 Brochure More information from Xarelto-Drug Insights,2014 Description: Xarelto - Drug Insights, 2014 provides Xarelto marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period ( ). The report also includes SWOT analysis for the drug. This report is built using data and information sourced from DelveInsight proprietary databases, primary and secondary research using Company s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by a team of industry experts. Data Sources The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases. Please note: this report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug. Scope - A review of the Xarelto based on information derived from company and industry-specific sources - Coverage of the Marketed data of the Xarelto on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification - Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Schizophrenia drugs with location details - Patent Expiry Timeline and Exclusivity Details - Route of Synthesis of the API - Global Forecasted Sales Figure from Qualitative and quantitative assessment of market space - SWOT Analysis Reasons to buy - Evaluate the marketing status and exclusivity details of Xarelto to exploit opportunities for generic drug development opportunities. - Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Xarelto. - API intelligence over Xarelto and gaining primary intelligence over Active Ingredients manufacturers across the globe. - Understanding the chemical route of synthesis of Xarelto. - Uncovering opportunities in the rapidly growing the US market - Stay ahead of competition by understanding the changing competitive landscape - Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential - Make more informed business decisions from insightful and in-depth analysis of the drug s performance - Obtain sales forecast for currently marketed drug for Contents: Table of Contents - Drug Overview

2 - Global Sales Assessment - Product Description - Mechanism of Action - Pharmacodynamic Properties - Pharmacokinetic Properties - Marketed Details for the United States - Marketed Details for the Europe - Patent Information - Patent and Exclusivity Expiry Assessment United States (US) - Patent Numbers and Expiry Details - Patent Details - Route of Synthesis - Global API Manufacturers Assessment - The United States Drug Master File (US DMF) - The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF) - The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region - The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status - The Active Pharmaceutical Ingredient (API) Manufacturers by Region - The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries - Generic Players - The Pipeline Coverage - Clinical Trials Information - Clinical Trials by Zone - Company Profile - Summary - Company Financials - SWOT Analysis - References - Appendix - Methodology - About DelveInsight - Contact Us - Disclaimer List of Tables - Xarelto, Market, Global Sales (in USD), Xarelto, Description - Xarelto, Marketed Details the United States (US) - Xarelto, Marketed Details the Europe (EU) - Xarelto, Patent/Exclusivity Expiry (Year), Xarelto, Patent Number Specific Patent Expiry (Year), Xarelto, Patent Details - Xarelto, Route of Synthesis - Xarelto, the United States Drug Master File (US DMF), Xarelto, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), Xarelto, the API Manufacturers, China, Xarelto, the API Manufacturers, India, Xarelto, the API Manufacturers by the US DMF Status, Xarelto, the API Manufacturers by Region, Xarelto, the API Manufacturers by Location/Countries, Xarelto, Generic Players, Xarelto, Pipeline Drug Details, Xarelto, Clinical Trials, Xarelto, Clinical Trials by Zone, Company Overview, Xarelto, SWOT Analysis, Phase III Pipeline Therapeutics, 2014 List of Figures - Xarelto, Market, Global Sales (in million USD), Xarelto, Global Sales % Change, Xarelto, Patent/Exclusivity Expiry (Year), 2014

3 - Xarelto, Patent Number Specific Patent Expiry (Year), Xarelto, Route of synthesis - Xarelto, the API Manufacturers by the US DMF Status (%), Xarelto, the API Manufacturers by Region, Xarelto, the API Manufacturers by Location/Countries, Xarelto, Generic Players, Xarelto, Clinical Trials by Zone (%), 2014 Ordering: Order Online - Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.

4 Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to (from USA) or (from Rest of World). If you have any questions please visit Order Information Please verify that the product information is correct and select the format(s) you require. Product Name: Web Address: Office Code: Xarelto-Drug Insights, SC Product Formats Please select the product formats and quantity you require: Electronic (PDF - 1 Month Sub.) - Single User: Electronic (PDF - 1 Month Sub.) - Site License: Electronic (PDF - 1 Month Sub.) - Enterprisewide: Quantity USD 800 USD Until 31st Dec 2015 USD 1400 USD Until 31st Dec 2015 USD 1800 USD Until 31st Dec 2015 Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: Last Name: Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number:

5 Page 1 of 2 Title: Mr Mrs Dr Miss Ms Prof * Please refrain from using free accounts when ordering (e.g. Yahoo, Hotmail, AOL)

6 Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card: You will receive an with a link to a secure webpage to enter your credit card details. Pay by check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland. Pay by wire transfer: Please transfer funds to: Account number Sort code Swift code IBAN number Bank Address ULSBIE2D IE78ULSB Ulster Bank, Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at Please fax this form to: (646) or (646) From USA or From Rest of World